Hepatitis C continues to be a major public health problem affecting approximately 3% of the global population.
According to the World Health Organization, an estimated 170 million people have chronic Hepatitis C.
Drs Ayse Mindikoglu and Ram Miller from Maryland, USA reviewed the epidemiology, natural history, and treatment of Hepatitis C in the elderly.
|5% will develop hepatocellular carcinoma|
|Clinical Gastroenterology & Hepatology
The team report that 10% to 20% of those who are chronically infected with Hepatitis C will progress to cirrhosis, and 5% will develop hepatocellular carcinoma.
The team found that the safety and efficacy of Hepatitis C therapies have been studied extensively in patients between the ages of 18 and 65.
However, the team reported that patients who are older than 65 still remain an understudied and difficult-to-treat population.
Dr Mindikoglu and colleague concluded, “This review discusses the epidemiology, natural history, and treatment of chronic Hepatitis C in older adults.”